The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABEONA THERAPEUTICS INC | COM | 00289Y107 | 1,375 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 5,075 | 290,000 | SH | SOLE | 290,000 | 0 | 0 | ||
AEVI GENOMIC MEDICINE INC | COM | 00835P105 | 1,990 | 1,070,000 | SH | SOLE | 1,070,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS | COM | 00847X104 | 7,592 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 876 | 36,500 | SH | SOLE | 36,500 | 0 | 0 | ||
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 1,418 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
ARQULE INC | COM | 04269E107 | 593 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 20,586 | 1,970,000 | SH | SOLE | 1,970,000 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADR | 09071M106 | 240 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
BLUEPRINT MEDICINES | COM | 09627Y109 | 35,191 | 880,000 | SH | SOLE | 880,000 | 0 | 0 | ||
CARA THERAPEUTICS | COM | 140755109 | 7,080 | 385,000 | SH | SOLE | 385,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 7,751 | 1,215,000 | SH | SOLE | 1,215,000 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 955 | 122,500 | SH | SOLE | 122,500 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 5,616 | 1,170,000 | SH | SOLE | 1,170,000 | 0 | 0 | ||
CORIUM INTERNATIONAL INC | COM | 21887L107 | 677 | 162,000 | SH | SOLE | 162,000 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 5,871 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
EAGLE PHARMACEUTICALS INC | COM | 269796108 | 4,147 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
EDGE THERAPEUTICS INC | COM | 279870109 | 2,550 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 3,080 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 8,134 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 2,475 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 6,211 | 960,000 | SH | SOLE | 960,000 | 0 | 0 | ||
IMPRIMIS PHARMACEUTICALS INC | COM NEW | 45323A201 | 3,588 | 860,500 | SH | SOLE | 860,500 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 770 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
LION BIOTECHNOLOGIES INC | COM | 53619R102 | 1,713 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
LOXO ONCOLOGY | COM | 548862101 | 5,470 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 5,874 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 3,186 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 7,840 | 730,000 | SH | SOLE | 730,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 5,104 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 1,959 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | COM | 74365AAB7 | 2,624 | 1,930,000 | SH | SOLE | 1,930,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 4,859 | 87,100 | SH | SOLE | 87,100 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 3,198 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
SANGAMO BIOSCIENCES INC | COM | 800677106 | 3,021 | 581,000 | SH | SOLE | 581,000 | 0 | 0 | ||
STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 5,605 | 1,180,000 | SH | SOLE | 1,180,000 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 2,255 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 400 | 25,149 | SH | SOLE | 25,149 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | COM | G8807B106 | 6,627 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
TONIX PHARMACEUTICALS HOLDING | COM NEW | 890260201 | 1,097 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 2,153 | 78,300 | SH | SOLE | 78,300 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,440 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 287 | 40,400 | SH | SOLE | 40,400 | 0 | 0 | ||
ZOSANO PHARMA CORP | COM | 98979H103 | 2,375 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 |